Page last updated: 2024-10-23

aspirin and Fetal Death

aspirin has been researched along with Fetal Death in 119 studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Fetal Death: Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH.

Research Excerpts

ExcerptRelevanceReference
"To evaluate the effect of low-dose aspirin in prevention of adverse pregnancy outcomes (APO) in women with second trimester alpha-fetoprotein (AFP) >2."9.19Effect of aspirin in prevention of adverse pregnancy outcome in women with elevated alpha-fetoprotein. ( Alavi, A; Borna, S; Hantoushzadeh, S; Khazardoost, S; Khezerlou, N; Mousavi, S, 2014)
"Aspirin desensitization may be a safe alternative even during pregnancy if carefully monitored and permit patients with APS to receive treatment with ASA."9.12Aspirin desensitization in the treatment of antiphospholipid syndrome during pregnancy in ASA-sensitive patients. ( Alijotas-Reig, J; Cisteró-Bahíma, A; San Miguel-Moncín, M, 2006)
"The results of this study do not support the routine prophylactic administration of low dose aspirin in pregnancy to any category of high risk women (even those who have chronic hypertension or who are considered to be especially liable to early onset pre-eclampsia)."9.08ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pré-eclampsia com Aspirina) Collaborative Group. ( , 1996)
"The effect of administration of a prophylactic dose of controlled-release aspirin on the prevention of pre-eclampsia was investigated in a randomized placebo-controlled trial conducted at the Queen Elizabeth Hospital in Barbados in 1992-94."9.08Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications. ( Ayers, S; Collins, R; Cruickshank, JK; Duley, L; Farrell, B; Gay, MP; Grant, A; Griffiths, J; Hennis, A; Rotchell, YE; Stewart, A, 1998)
"A multicentric randomized double-blind trial was realized in order to determine whether a treatment with a low-dose aspirin (150 mg/day) with or without dipyridamole (225 mg/day) was able to prevent the perinatal consequences of pre-eclampsia."9.07Prevention of perinatal consequences of pre-eclampsia with low-dose aspirin: results of the epreda trial. The Epreda Trial Study Group. ( Sureau, C, 1991)
"We assessed the effects and safety of aspirin treatment during pregnancy on fetal and neonatal outcomes."8.82Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis. ( Boskovic, R; Costei, AM; Koren, G; Kozer, E; Nikfar, S; Nulman, I, 2003)
" Considering the clear risk of complications during pregnancy -- especially the occurrence of spontaneous abortion in the first trimester -- and the risk of intrauterine fetal death, we believe all patients should at least be treated with aspirin unless there is a contraindication."8.81Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment. A comparative analysis of the literature. ( Vanstraelen, D; Vantroyen, B, 2002)
" In patients with arterial or venous thrombosis, there is a high rate of recurrence during the two first years except if high-dose warfarin was used (i."8.80[Aspirin and antiphospholipid syndrome]. ( Blétry, O; Hachulla, E; Hatron, PY; Piette, AM, 2000)
"Recent surveys of prenatal drug consumption indicate that aspirin is the most frequently consumed drug in pregnancy."8.75Aspirin in pregnancy: maternal and fetal effects. ( Corby, DG, 1978)
"To evaluate the prevalence and perinatal repercussions of preeclampsia (PE) after the implementation of a prophylaxis protocol with aspirin in singleton pregnancy at Maternity School of Federal University of Rio de Janeiro, Rio de Janeiro, Brazil (2015-2106)."8.31The prevalence and perinatal repercussions of preeclampsia after the implementation of a prophylaxis protocol with aspirin. ( Amim, J; Bornia, RG; Cardoso, FFO; Cardoso, MIMP; Costa Junior, IB; Da Matta, FG; Gama, LB; Rezende, KBC; Saunders, C, 2023)
"When platelet function was assessed with COX-specific tests that measure the antiplatelet effects of low-dose aspirin and aspirin adherence is accurately accounted for aspirin non-responsiveness was not identified in pregnant women at high-risk of pre-eclampsia."7.88Aspirin non-responsiveness in pregnant women at high-risk of pre-eclampsia. ( Alfirevic, A; Alfirevic, Z; Jorgensen, A; Navaratnam, K, 2018)
"To evaluate the benefit of treatment with dalteparin and low-dose aspirin (ASA) in the prevention of obstetric complications in women with inherited thrombophilia."7.74Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia. ( David, M; Dubois, E; Leduc, L; Rey, E; Takser, L, 2007)
"Descriptions of salicylate poisoning during pregnancy are rare and unique features of perinatal physiology predict an increased sensitivity of the fetus to aspirin poisoning."7.70Aspirin poisoning during pregnancy: increased fetal sensitivity. ( Palatnick, W; Tenenbein, M, 1998)
"Despite an improvement in outcomes in the aspirin treated pregnancy, histologic evidence of uterine vascular pathology persisted in the majority of women with a prior complicated pregnancy demonstrating similar placental lesions."7.69Low-dose aspirin therapy and placental pathology in women with poor prior pregnancy outcomes. ( Campbell, WA; Cusick, W; Ernst, L; Rodis, JF; Salafia, CM; Vintzileos, AM, 1995)
" Many studies have suggested that treatment with low-dose aspirin and steroids is effective in preventing pregnancy loss or pre-eclampsia, but the mechanism has not been established."7.68[A trial of low-dose aspirin therapy in high-risk pregnancy]. ( Mochizuki, M; Morikawa, H; Ohashi, M; Takashima, M; Yamasaki, M, 1992)
"A 27-year-old woman with anti-phospholipid antibody syndrome, whose first pregnancy had ended in intrauterine fetal death, was treated with prednisolone 0."7.68[Fetal survival after the corticosteroid and low-dose aspirin regimen in a case of anti-phospholipid antibody syndrome]. ( Maruyama, I; Maruyama, Y; Okadome, T; Osame, M; Shimmyozu, K; Tara, M, 1990)
" there was no evidence that aspirin taken in pregnancy is a cause of stillbirth, neonatal death, or reduced birth-weight."7.65Perinatal mortality and birth-weight in relation to aspirin taken during pregnancy. ( Heinonen, OP; Kaufman, DW; Monson, RR; Shapiro, S; Siskind, V; Slone, D, 1976)
"Aspirin was not associated with a significant increase in placental haemorrhages or in bleeding during preparation for epidural anaesthesia, but there was a slight increase in use of blood transfusion after delivery."6.67CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. ( , 1994)
"Its use during pregnancy is considered as safe, provided the daily doses do not exceed 100mg."6.55[Aspirin: Indications and use during pregnancy]. ( Belhomme, N; Doudnikoff, C; Henriot, B; Isly, H; Jego, P; Polard, E, 2017)
"After treatment the pregnancy wastage rate was 55% and 25% in the 2 groups respectively."5.28Pregnancy loss with phospholipid antibodies: improved outcome with aspirin containing treatment. ( Cameron, K; Gatenby, PA; Shearman, RP, 1989)
"To evaluate the effect of low-dose aspirin in prevention of adverse pregnancy outcomes (APO) in women with second trimester alpha-fetoprotein (AFP) >2."5.19Effect of aspirin in prevention of adverse pregnancy outcome in women with elevated alpha-fetoprotein. ( Alavi, A; Borna, S; Hantoushzadeh, S; Khazardoost, S; Khezerlou, N; Mousavi, S, 2014)
"Aspirin desensitization may be a safe alternative even during pregnancy if carefully monitored and permit patients with APS to receive treatment with ASA."5.12Aspirin desensitization in the treatment of antiphospholipid syndrome during pregnancy in ASA-sensitive patients. ( Alijotas-Reig, J; Cisteró-Bahíma, A; San Miguel-Moncín, M, 2006)
"The effect of administration of a prophylactic dose of controlled-release aspirin on the prevention of pre-eclampsia was investigated in a randomized placebo-controlled trial conducted at the Queen Elizabeth Hospital in Barbados in 1992-94."5.08Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications. ( Ayers, S; Collins, R; Cruickshank, JK; Duley, L; Farrell, B; Gay, MP; Grant, A; Griffiths, J; Hennis, A; Rotchell, YE; Stewart, A, 1998)
"The results of this study do not support the routine prophylactic administration of low dose aspirin in pregnancy to any category of high risk women (even those who have chronic hypertension or who are considered to be especially liable to early onset pre-eclampsia)."5.08ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pré-eclampsia com Aspirina) Collaborative Group. ( , 1996)
"A multicentric randomized double-blind trial was realized in order to determine whether a treatment with a low-dose aspirin (150 mg/day) with or without dipyridamole (225 mg/day) was able to prevent the perinatal consequences of pre-eclampsia."5.07Prevention of perinatal consequences of pre-eclampsia with low-dose aspirin: results of the epreda trial. The Epreda Trial Study Group. ( Sureau, C, 1991)
"The use of aspirin and heparin has improved the pregnancy outcome in obstetric APS and approximately 70% of pregnant women with APS have a successful pregnancy outcome."4.95Current insights in obstetric antiphospholipid syndrome. ( Radin, M; Schreiber, K; Sciascia, S, 2017)
"Databases were searched for keywords related to aspirin and pregnancy."4.89Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. ( Bujold, E; Demers, S; Nicolaides, KH; Roberge, S; Villa, P, 2013)
" Low dose aspirin should be given to every pregnant woman with antiphospholipid antibodies, with the addition of low molecular weight heparin in those with previous thrombosis, previous fetal death or failure of monotherapy with aspirin."4.85[The antiphospholipid syndrome in the 21st century]. ( Egurbide, MV; Martinez-Berriotxoa, A; Ruiz-Irastorza, G, 2009)
"Antiplatelet agents, largely low-dose aspirin, have moderate benefits when used for prevention of pre-eclampsia and its consequences."4.84Antiplatelet agents for preventing pre-eclampsia and its complications. ( Duley, L; Henderson-Smart, DJ; King, JF; Meher, S, 2007)
"We assessed the effects and safety of aspirin treatment during pregnancy on fetal and neonatal outcomes."4.82Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis. ( Boskovic, R; Costei, AM; Koren, G; Kozer, E; Nikfar, S; Nulman, I, 2003)
"Although intra-uterine fetal death is considered at high risk of recurrence in case of antiphospholipid syndrome (APS), a uniform management protocol including aspirin and heparin and close obstetrical follow-up led to a favorable outcome in most cases."4.82Antiphospholipid syndrome and second- or third-trimester fetal death: follow-up in the next pregnancy. ( Bats, AS; Carbonne, B; Cynober, E; Gonzales, M; Lejeune, V; Milliez, J; Safar, E, 2004)
"Antiplatelet drugs, largely low dose aspirin, have small to moderate benefits when used for prevention of pre-eclampsia."4.81Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. ( Duley, L; Henderson-Smart, D; King, J; Knight, M, 2001)
" Considering the clear risk of complications during pregnancy -- especially the occurrence of spontaneous abortion in the first trimester -- and the risk of intrauterine fetal death, we believe all patients should at least be treated with aspirin unless there is a contraindication."4.81Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment. A comparative analysis of the literature. ( Vanstraelen, D; Vantroyen, B, 2002)
" In patients with arterial or venous thrombosis, there is a high rate of recurrence during the two first years except if high-dose warfarin was used (i."4.80[Aspirin and antiphospholipid syndrome]. ( Blétry, O; Hachulla, E; Hatron, PY; Piette, AM, 2000)
"Recent surveys of prenatal drug consumption indicate that aspirin is the most frequently consumed drug in pregnancy."4.75Aspirin in pregnancy: maternal and fetal effects. ( Corby, DG, 1978)
"To evaluate the prevalence and perinatal repercussions of preeclampsia (PE) after the implementation of a prophylaxis protocol with aspirin in singleton pregnancy at Maternity School of Federal University of Rio de Janeiro, Rio de Janeiro, Brazil (2015-2106)."4.31The prevalence and perinatal repercussions of preeclampsia after the implementation of a prophylaxis protocol with aspirin. ( Amim, J; Bornia, RG; Cardoso, FFO; Cardoso, MIMP; Costa Junior, IB; Da Matta, FG; Gama, LB; Rezende, KBC; Saunders, C, 2023)
"When platelet function was assessed with COX-specific tests that measure the antiplatelet effects of low-dose aspirin and aspirin adherence is accurately accounted for aspirin non-responsiveness was not identified in pregnant women at high-risk of pre-eclampsia."3.88Aspirin non-responsiveness in pregnant women at high-risk of pre-eclampsia. ( Alfirevic, A; Alfirevic, Z; Jorgensen, A; Navaratnam, K, 2018)
"All consecutive women between 24 and 36weeks gestation with an indication for aspirin use during pregnancy were invited for this study."3.83Aspirin adherence during high-risk pregnancies, a questionnaire study. ( Abheiden, CN; de Boer, MA; de Vries, JI; Fuijkschot, WW; Thijs, A; van Reuler, AV, 2016)
"To identify patients at very high risk for adverse pregnancy outcome (APO) at the 20- to 23-week scan and to assess the effectiveness of Aspirin (ASS) and low molecular weight heparin (LMWH) starting after this examination."3.79Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspects. ( Becker, R; Bittner, U; Fangerau, H; Keller, T; Kiesewetter, H, 2013)
"To evaluate the benefit of treatment with dalteparin and low-dose aspirin (ASA) in the prevention of obstetric complications in women with inherited thrombophilia."3.74Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia. ( David, M; Dubois, E; Leduc, L; Rey, E; Takser, L, 2007)
"Descriptions of salicylate poisoning during pregnancy are rare and unique features of perinatal physiology predict an increased sensitivity of the fetus to aspirin poisoning."3.70Aspirin poisoning during pregnancy: increased fetal sensitivity. ( Palatnick, W; Tenenbein, M, 1998)
"To our knowledge, this is the first time that a combination of aspirin and glyceryl trinitrate (GTN) has been used in the prophylaxis of preeclampsia and fetal growth retardation, and their use associated with not only Doppler screening of the uterine arteries but also regular Doppler follow-up of the fetal arterial and venous circulation."3.70A novel approach to the management of pregnancies complicated by uteroplacental insufficiency and previous stillbirth. ( Black, RS; Campbell, S; Lees, CC; Oyelese, KO, 1998)
" In 1982, it was suggested for the first time low doses of aspirin and prednisone for treatment of recurrent fetal death associated to this syndrome, heparin therapy was reported in 1984, recommended a doses of 15,000 U/day during first pregnancy trimester and 20,000 U/day posteriorly."3.69[Recurrent fetal death and antiphospholipid antibody syndrome. A case report]. ( Bustos López, HH; Hernández Andrade, E; Ramírez Peredo, J; Rojas-Poceros, G, 1997)
"Despite an improvement in outcomes in the aspirin treated pregnancy, histologic evidence of uterine vascular pathology persisted in the majority of women with a prior complicated pregnancy demonstrating similar placental lesions."3.69Low-dose aspirin therapy and placental pathology in women with poor prior pregnancy outcomes. ( Campbell, WA; Cusick, W; Ernst, L; Rodis, JF; Salafia, CM; Vintzileos, AM, 1995)
" Many studies have suggested that treatment with low-dose aspirin and steroids is effective in preventing pregnancy loss or pre-eclampsia, but the mechanism has not been established."3.68[A trial of low-dose aspirin therapy in high-risk pregnancy]. ( Mochizuki, M; Morikawa, H; Ohashi, M; Takashima, M; Yamasaki, M, 1992)
"A 27-year-old woman with anti-phospholipid antibody syndrome, whose first pregnancy had ended in intrauterine fetal death, was treated with prednisolone 0."3.68[Fetal survival after the corticosteroid and low-dose aspirin regimen in a case of anti-phospholipid antibody syndrome]. ( Maruyama, I; Maruyama, Y; Okadome, T; Osame, M; Shimmyozu, K; Tara, M, 1990)
" During their next pregnancy, the patients were treated with 40 to 50 mg of prednisone per day and 81 mg of aspirin per day."3.67Obstetric complications associated with the lupus anticoagulant. ( Branch, DW; Hershgold, E; Kochenour, NK; Scott, JR, 1985)
" there was no evidence that aspirin taken in pregnancy is a cause of stillbirth, neonatal death, or reduced birth-weight."3.65Perinatal mortality and birth-weight in relation to aspirin taken during pregnancy. ( Heinonen, OP; Kaufman, DW; Monson, RR; Shapiro, S; Siskind, V; Slone, D, 1976)
"Aspirin was not associated with a significant increase in placental haemorrhages or in bleeding during preparation for epidural anaesthesia, but there was a slight increase in use of blood transfusion after delivery."2.67CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. ( , 1994)
"Its use during pregnancy is considered as safe, provided the daily doses do not exceed 100mg."2.55[Aspirin: Indications and use during pregnancy]. ( Belhomme, N; Doudnikoff, C; Henriot, B; Isly, H; Jego, P; Polard, E, 2017)
"Adequate pregnancy care of women with systemic lupus erythematosus (SLE) rests on three pillars: a coordinated medical-obstetrical care, an agreed and well-defined management protocol and a good neonatal unit."2.47Lupus and pregnancy: integrating clues from the bench and bedside. ( Khamashta, MA; Ruiz-Irastorza, G, 2011)
"Antiphospholipid syndrome is one of the few treatable causes of pregnancy loss, and successful pregnancy rates of 70% or more can be achieved with appropriate treatment."2.44[Pregnancy and antiphospholipid antibodies]. ( Goffinet, F; Le Guern, V, 2008)
"Many authors relate this factor with preeclampsia, intrauterine fetal growth retardation, spontaneous abortion, unexplained cases of still birth, placental abruption, and thromboembolic complications during and after parturition."2.42[Factor V Leiden mutation and pregnancy complications]. ( Abraitis, V; Mockeviciene, A; Mongirdiene, A, 2003)
"Recently, the thrombophilias have been revealed as risk factors for severe preeclampsia, abruptio placentae, fetal growth retardation, abortion and still birth as well."2.42[Anticoagulation and antiaggregation during pregnancy]. ( Biasiutti, FD; Strebel, JK, 2003)
"If diagnosed and treated early in pregnancy with low-dose aspirin and subcutaneous heparin the outlook for a successful pregnancy is much improved."2.41A literature review on the antiphospholipid syndrome and the effect on childbearing. ( Vials, JM, 2001)
"Aspirin (ASS) was the most frequently used drug in 47 of 93 recorded cases (51%)."2.39Essential thrombocythemia and pregnancy. ( Griesshammer, M; Heimpel, H; Pearson, TC, 1996)
" The teratogenic potential of a drug is related to dosage and time of administration."2.36Analgesics during pregnancy. ( Niederhoff, H; Zahradnik, HP, 1983)
"Eleven women with recurrent miscarriage (14."1.42Clinical characteristics of pregnancies with a history of recurrent miscarriage at a Japanese perinatal center. ( Nakanishi, K; Suzuki, S; Terada, K, 2015)
"Last, we show that the recurrence rate of an adverse pregnancy outcome persisted at 30% despite treatment intervention."1.42Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study. ( Botta, A; Bucourt, M; Carbillon, L; Chollet-Martin, S; Chudzinski, A; Cornelis, F; Costedoat-Chalumeau, N; De Carolis, S; Emmanuelli, V; Fain, O; Hachulla, E; Masseau, A; Mekinian, A; Montestruc, F; Nicaise, P; Revaux, A; Subtil, D; Theulin, A, 2015)
"No patients with preeclampsia or other severe complications of pregnancy were observed in the normalised group."1.31Late normalisation of uterine artery velocimetry in high risk pregnancy. ( Danti, L; Frusca, T; Scalvi, L; Soregaroli, M; Valcamonico, A, 2001)
"Management of ET in pregnancy is still very much individualized."1.31Four pregnancies in two patients with essential thrombocythaemia--a case report. ( Devendra, K; Koh, LP; Tien, SL, 2002)
"Increased risk for aplasia cutis congenita should be considered when elevated maternal and amniotic fluid alpha-fetoprotein and a distinct electrophoretic band of acetylcholinesterase are found."1.29Aplasia cutis congenita, elevated alpha-fetoprotein, and a distinct amniotic fluid acetylcholinesterase electrophoretic band. ( Cohen, RN; Dror, Y; Gelman-Kohan, Z; Hagai, Z; Juster-Reicher, A; Mogilner, B, 1994)
"The patient had experienced hepatic infarction during her first pregnancy and had repeated hepatic infarction during her third pregnancy."1.29Hepatic infarction during pregnancy complicated by antiphospholipid syndrome. ( Kinoshita, K, 1993)
"Thrombotic thrombocytopenic purpura is a severe multisystemic disorder of unknown origin."1.28Successful pregnancies of two patients with relapsing thrombotic thrombocytopenic purpura. ( Eldor, A; Ezra, Y; Mordel, N; Sadovsky, E; Schenker, JG, 1989)
"After treatment the pregnancy wastage rate was 55% and 25% in the 2 groups respectively."1.28Pregnancy loss with phospholipid antibodies: improved outcome with aspirin containing treatment. ( Cameron, K; Gatenby, PA; Shearman, RP, 1989)
"A clinical diagnosis of systemic lupus erythematosus (SLE) was made in four women."1.27Lupus anticoagulant in pregnancy. ( Butler, WS; Liggins, GC; Lubbe, WF; Palmer, SJ, 1984)
"Beagle bitches were administered aspirin at either 100 or 400 mg/kg/day between Days 15 and 22 or Days 23 and 30 postmating, and corresponding control groups were dosed with vehicle during one of these same time periods."1.26Aspirin: teratogenic evaluation in the dog. ( Allen, HL; Bokelman, DL; Robertson, RT, 1979)

Research

Studies (119)

TimeframeStudies, this research(%)All Research%
pre-199039 (32.77)18.7374
1990's37 (31.09)18.2507
2000's28 (23.53)29.6817
2010's13 (10.92)24.3611
2020's2 (1.68)2.80

Authors

AuthorsStudies
Cardoso, MIMP1
Rezende, KBC1
Da Matta, FG1
Saunders, C1
Cardoso, FFO1
Costa Junior, IB1
Gama, LB1
Amim, J1
Bornia, RG1
Gangat, N1
Guglielmelli, P1
Al-Kali, A1
Wolanskyj-Spinner, AP1
Camoriano, J1
Patnaik, MM1
Pardanani, A1
Hanson, CA1
Vannucchi, AM1
Tefferi, A2
Schreiber, K1
Radin, M1
Sciascia, S1
Belhomme, N1
Doudnikoff, C1
Polard, E1
Henriot, B1
Isly, H1
Jego, P1
Navaratnam, K1
Alfirevic, A1
Jorgensen, A1
Alfirevic, Z1
Khazardoost, S1
Mousavi, S1
Borna, S1
Hantoushzadeh, S1
Alavi, A1
Khezerlou, N1
Mekinian, A2
Costedoat-Chalumeau, N1
Masseau, A1
Botta, A1
Chudzinski, A1
Theulin, A1
Emmanuelli, V1
Hachulla, E2
De Carolis, S1
Revaux, A1
Nicaise, P1
Cornelis, F1
Subtil, D1
Montestruc, F1
Bucourt, M1
Chollet-Martin, S2
Carbillon, L2
Fain, O2
Mutlu, I1
Mutlu, MF1
Biri, A1
Bulut, B1
Erdem, M1
Erdem, A1
Terada, K1
Nakanishi, K1
Suzuki, S1
Abheiden, CN1
van Reuler, AV1
Fuijkschot, WW1
de Vries, JI1
Thijs, A1
de Boer, MA1
Le Guern, V1
Goffinet, F1
Ruiz-Irastorza, G2
Martinez-Berriotxoa, A1
Egurbide, MV1
Ogishima, H1
Ito, S1
Tsutsumi, A1
Sugihara, M1
Goto, D1
Matsumoto, I1
Obata-Yasuoka, M1
Hamada, H1
Yoshikawa, H1
Takahashi, H1
Murashima, A1
Sumida, T1
Khamashta, MA1
Loire-Berson, P1
Nicaise-Roland, P1
Lachassinne, E1
Stirnemann, J1
Boffa, MC1
Roberge, S1
Nicolaides, KH1
Demers, S1
Villa, P1
Bujold, E1
Becker, R1
Keller, T1
Kiesewetter, H1
Fangerau, H1
Bittner, U1
Biasiutti, FD1
Strebel, JK1
Kozer, E1
Costei, AM1
Boskovic, R1
Nulman, I1
Nikfar, S1
Koren, G1
EARLEY, PA1
HAYDEN, J1
Abraitis, V1
Mongirdiene, A1
Mockeviciene, A1
Gris, JC1
Mercier, E1
Quéré, I1
Lavigne-Lissalde, G1
Cochery-Nouvellon, E1
Hoffet, M1
Ripart-Neveu, S1
Tailland, ML1
Dauzat, M1
Marès, P1
Bats, AS1
Lejeune, V1
Cynober, E1
Safar, E1
Gonzales, M1
Milliez, J1
Carbonne, B1
Gromnica-Ihle, E1
Wisløff, F1
Crowther, M1
Niittyvuopio, R1
Juvonen, E1
Kaaja, R2
Oksanen, K1
Hallman, H1
Timonen, T1
Ruutu, T1
Verspyck, E1
Marpeau, L1
Alijotas-Reig, J1
San Miguel-Moncín, M1
Cisteró-Bahíma, A1
Mégarbane, B1
Baud, F1
Kornacka, MK1
Bokiniec, R1
Duley, L3
Henderson-Smart, DJ1
Meher, S1
King, JF1
Hossain, N1
Paidas, MJ1
Leduc, L1
Dubois, E1
Takser, L1
Rey, E1
David, M1
Chandiramani, M1
Seed, P1
Poston, L1
Shennan, AH1
Lubbe, WF3
Butler, WS2
Palmer, SJ2
Liggins, GC3
Niederhoff, H1
Zahradnik, HP1
Grabowski, CT1
Vandekerckhove, F1
Noens, L1
Colardyn, F1
Thiery, M1
Delbarge, W1
Goodlin, RC1
Machlin, LJ1
Gabriel, E1
Horn, LR1
Woo, D1
Filipski, R1
Brin, M1
Nelson, J1
Dror, Y1
Gelman-Kohan, Z1
Hagai, Z1
Juster-Reicher, A1
Cohen, RN1
Mogilner, B1
Zahner, J1
Wehmeier, A1
Schneider, W1
Moya, FR1
Germain, A1
Kinoshita, K1
Stuart, RA1
Quinn, MJ1
McHugh, NJ1
Rogov, VA1
Tareeva, IE1
Sidorova, IS1
Androsova, SO1
Katamadze, KT1
Nikiforova, OV1
Carp, HJ1
Menashe, Y1
Frenkel, Y1
Many, A1
Nebel, L1
Toder, V1
Mashiach, S1
Cusick, W1
Salafia, CM1
Ernst, L1
Rodis, JF1
Campbell, WA1
Vintzileos, AM1
Ezra, Y2
Rose, M1
Eldor, A2
McCowan, LM1
Buist, RG1
North, RA1
Gamble, G1
Cowchock, S1
Griesshammer, M1
Heimpel, H1
Pearson, TC1
Mazzucconi, MG1
Dragoni, F1
Chistolini, A1
Peraino, M1
Paesano, R1
Di Prima, M1
Di Francesco, F1
Masala, C1
Pachì, A1
Reece, EA1
Garofalo, J1
Zheng, XZ1
Assimakopoulos, E1
González Campos, J1
Monedero, M1
Vinuesa, M1
Alvarez, D1
Digón, J1
Rodríguez, JM1
Palatnick, W1
Tenenbein, M1
Rojas-Poceros, G1
Ramírez Peredo, J1
Hernández Andrade, E1
Bustos López, HH1
Rotchell, YE1
Cruickshank, JK1
Gay, MP1
Griffiths, J1
Stewart, A1
Farrell, B1
Ayers, S1
Hennis, A1
Grant, A1
Collins, R1
Cyrkowicz, A1
Przybycień, J1
Sullivan, MH1
Clark, NA1
de Swiet, M1
Nelson-Piercy, C1
Elder, MG1
Oyelese, KO1
Black, RS1
Lees, CC1
Campbell, S1
Costa, M1
Rossi, E1
Julkunen, H1
Jouhikainen, T1
Piette, AM1
Hatron, PY1
Blétry, O1
Kaburaki, J1
Kuwana, M1
Henderson-Smart, D1
Knight, M1
King, J1
Soregaroli, M1
Valcamonico, A1
Scalvi, L1
Danti, L1
Frusca, T1
Wright, CA1
Vials, JM1
Erkan, D1
Merrill, JT1
Yazici, Y1
Sammaritano, L1
Buyon, JP1
Lockshin, MD2
Maharaj, R1
Vantroyen, B1
Vanstraelen, D1
Koh, LP1
Devendra, K1
Tien, SL1
Shapiro, S1
Siskind, V1
Monson, RR1
Heinonen, OP1
Kaufman, DW1
Slone, D1
Collins, E1
Turner, G1
Karim, SM1
Corby, DG1
Wilson, JG2
Ritter, EJ1
Scott, WJ1
Fradkin, R1
Robertson, RT1
Allen, HL1
Bokelman, DL1
Woo, DC1
McClain, RM1
Hoar, RM1
O'Dell, BL1
Reynolds, G1
Reeves, PG1
Fritz, H1
Tuchmann-Duplessis, H1
Hiss, D1
Mottot, G1
Rosner, I1
Faivre, J1
Faivre, M1
Lery, N1
Mukherjee, AB1
Chan, M1
Waite, R1
Metzger, MI1
Yaffee, SJ1
Passaleva, A1
Massai, G1
D'Elios, MM1
Livi, C1
Abbate, R1
Sedano, M1
Palma, S1
González, P1
Neira, O1
Abumohor, P1
Cerda, C1
Guzmán, L1
Takashima, M1
Yamasaki, M1
Ohashi, M1
Morikawa, H1
Mochizuki, M1
Font, J1
López-Soto, A1
Cervera, R1
Balasch, J1
Pallarés, L1
Navarro, M1
Bosch, X1
Ingelmo, M1
Sureau, C1
Wise, LD1
Vetter, CM1
Anderson, CA1
Antonello, JM1
Clark, RL1
Randall, CL1
Anton, RF1
Becker, HC1
Hale, RL1
Ekblad, U1
Branch, DW2
Pineo, GF1
Blahey, WB1
Keirse, MJ1
Shimmyozu, K1
Okadome, T1
Maruyama, Y1
Maruyama, I1
Osame, M1
Tara, M1
Gendron, RL1
Farookhi, R1
Baines, MG1
Mordel, N1
Sadovsky, E1
Schenker, JG1
Gatenby, PA1
Cameron, K1
Shearman, RP1
Wallenburg, HC1
Rotmans, N1
Druzin, ML1
Qamar, T1
Scott, JR1
Kochenour, NK1
Hershgold, E1
Rejent, TA1
Baik, S1
Courtney, KD1
Valerio, DA1
Eriksson, M2
MacDonald, PC1
Schultz, FM1
Duenhoelter, JH1
Gant, NF1
Jimenez, JM1
Pritchard, JA1
Porter, JC1
Johnston, JM1
Kriegel, H1
Waltman, R1
Tricomi, V1
Shabanah, EH1
Arenas, R1
Aiken, JW1
Chester, R1
Dukes, M1
Slater, SR1
Walpole, AL1
Jewett, JF1
Crombie, DL1
Pinsent, RJ1
Slater, BC1
Fleming, D1
Cross, KW1
Kimmel, CA1
Schumacher, HJ1
Pap, AG1
Tarakhovskiĭ, ML1

Clinical Trials (12)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population[NCT05089175]4,500 participants (Anticipated)Observational [Patient Registry]2021-11-30Recruiting
A Randomized Controlled Trial Comparing Low Doses Of Aspirin In The Prevention Of Preeclampsia (ASAPP)[NCT04070573]Phase 3400 participants (Anticipated)Interventional2019-10-21Enrolling by invitation
Evaluation of the Benefit of Adjuvant Treatment With Hydroxychloroquine to the Usual Medical Management for Obtaining an Uncomplicated Term Pregnancy in Primary Obstetric Antiphospholipid Syndrome[NCT04275778]Phase 2110 participants (Anticipated)Interventional2021-07-09Recruiting
Genetic, Laboratory and Clinical Factors Associated With Low-dose Aspirin Failure in the Prevention of Preeclampsia- An Exploratory Protocol[NCT05709483]Early Phase 1130 participants (Anticipated)Interventional2023-04-13Recruiting
Low Dose Aspirin in the Prevention of Preeclampsia in Chinese Pregnant Women.[NCT02797249]Phase 31,000 participants (Actual)Interventional2016-12-07Completed
PEPPI Study: Identification of Women at Risk for Placental Dysfunction During the First and Third Trimesters of Pregnancy[NCT06115122]3,000 participants (Anticipated)Observational [Patient Registry]2022-02-15Recruiting
Aspirin for the Prevention of Preeclampsia in Women With Stage 1 Hypertension: A Pilot Study[NCT04908982]Phase 460 participants (Anticipated)Interventional2021-05-28Recruiting
Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN)[NCT02409680]11,976 participants (Actual)Interventional2016-03-23Completed
Induction of Labor at Term Versus Expectant Management Among Women With Abnormal Maternal Serum Biochemical Markers: A Randomized Controlled Trial[NCT02754635]320 participants (Anticipated)Interventional2016-03-31Recruiting
Certolizumab to Prevent Pregnancy Complications in High-Risk Patients With APS or SLE - (IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy)[NCT03152058]Phase 255 participants (Anticipated)Interventional2017-05-17Recruiting
Serum Assessment of Preterm Birth: Outcomes Compared to Historical Controls[NCT03151330]2,110 participants (Anticipated)Interventional2018-06-15Active, not recruiting
A Study of the Pharmacology of 17-Hydroxyprogesterone Caproate in Pregnancy[NCT00409825]Phase 261 participants (Actual)Interventional2006-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Fetal Outcome 1 - Incidence of Early Preterm Delivery (<34 Weeks)

- Early preterm delivery (<34 weeks) (NCT02409680)
Timeframe: At delivery

InterventionParticipants (Count of Participants)
Intervention Arm189
Placebo Arm230

Fetal Outcome 2 - Incidence of Actual Birth Weight <2500g

- Birth weight <2500g (NCT02409680)
Timeframe: At delivery

InterventionParticipants (Count of Participants)
Intervention Arm1078
Placebo Arm1153

Fetal Outcome 3 - Incidence of Actual Birth Weight <1500g

- Birth weight <1500g (NCT02409680)
Timeframe: At delivery

InterventionParticipants (Count of Participants)
Intervention Arm78
Placebo Arm101

Fetal Outcome 4 - Incidence of Fetal Loss

- Incidence of Fetal Loss (NCT02409680)
Timeframe: At delivery

InterventionParticipants (Count of Participants)
Intervention Arm303
Placebo Arm353

Fetal Outcome 5 - Incidence of Spontaneous Abortion

- Incidence of Spontaneous Abortion (NCT02409680)
Timeframe: At delivery

InterventionParticipants (Count of Participants)
Intervention Arm134
Placebo Arm152

Fetal Outcome 6 - Incidence of All Stillbirth

- Incidence of All stillbirth (NCT02409680)
Timeframe: At delivery

InterventionParticipants (Count of Participants)
Intervention Arm141
Placebo Arm166

Fetal Outcome 7 - Incidence of Medical Termination of Pregnancy

- Incidence of Medical Termination of Pregnancy (NCT02409680)
Timeframe: At delivery

InterventionParticipants (Count of Participants)
Intervention Arm42
Placebo Arm30

Incidence of Hypertensive Disorders of Pregnancy

- Hypertensive disorders of pregnancy is defined by the characterization of evidence of a hypertensive disorder, including either preeclampsia or eclampsia occurring during the pregnancy. (NCT02409680)
Timeframe: Evidence of hypertensive disorder during the pregnancy (prior to delivery/birth)

InterventionParticipants (Count of Participants)
Intervention Arm352
Placebo Arm325

Incidence of Perinatal Mortality

- Incidence of Perinatal Mortality (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery

InterventionParticipants (Count of Participants)
Intervention Arm264
Placebo Arm309

Incidence of Preterm Birth

The primary outcome of this study is incidence of preterm birth, which will be defined as delivery at or after 20 0/7 weeks and prior to 37 0/7 weeks. This will be determined based on actual date of delivery in comparison to the projected estimated due date (EDD), independent of whether or not the preterm delivery is indicated or spontaneous. (NCT02409680)
Timeframe: At delivery

InterventionParticipants (Count of Participants)
Intervention Arm668
Placebo Arm754

Incidence of Small for Gestational Age (SGA)

- Small for gestational age (SGA) as defined by the INTERGROWTH-21st standard (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery

InterventionParticipants (Count of Participants)
Intervention Arm1506
Placebo Arm1564

Maternal Outcome 1 - Incidence of Vaginal Bleeding

- Vaginal bleeding (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery

InterventionParticipants (Count of Participants)
Intervention Arm214
Placebo Arm246

Maternal Outcome 2 - Incidence of Antepartum Hemorrhage

- Antepartum hemorrhage (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery

InterventionParticipants (Count of Participants)
Intervention Arm26
Placebo Arm25

Maternal Outcome 3 - Incidence of Postpartum Hemorrhage

- Postpartum hemorrhage (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery

InterventionParticipants (Count of Participants)
Intervention Arm54
Placebo Arm43

Maternal Outcome 4 - Incidence of Maternal Mortality

- Incidence of Maternal Mortality (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery

InterventionParticipants (Count of Participants)
Intervention Arm9
Placebo Arm12

Maternal Outcome 5 - Incidence of Late Abortion

- Incidence of Late Abortion (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery

InterventionParticipants (Count of Participants)
Intervention Arm23
Placebo Arm30

Maternal Outcome 6 - Change in Maternal Hemoglobin

Hemoglobin < 7.0 gm/dl at 26-30 weeks gestation or a drop of 3.5+ gm/dl from screening to 26-30 weeks gestation (NCT02409680)
Timeframe: At enrollment, 4 weeks post enrollment, and 26-30 weeks GA.

InterventionParticipants (Count of Participants)
Intervention Arm290
Placebo Arm333

Maternal Outcome 7 - Incidence of Preterm, Preeclampsia

Early preterm delivery (<34 weeks) and hypertensive disorders (i.e.: preeclampsia) (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery

InterventionParticipants (Count of Participants)
Intervention Arm8
Placebo Arm21

Change in the Area Under the Concentration vs. Time Curve in the Second and Third Trimesters of Pregnancy.

"Change in the area under the concentration vs. time curve in the second and third trimesters of pregnancy.~We compared AUC at each PK study visit. Measurements were obtained at 0, 1, 2, 3, 4, 5, 6, 7 days." (NCT00409825)
Timeframe: Second and third trimesters of pregnancy

Interventionng/ML/day (Mean)
AUC -1AUC - 2
Part 1115136

Reviews

36 reviews available for aspirin and Fetal Death

ArticleYear
Current insights in obstetric antiphospholipid syndrome.
    Current opinion in obstetrics & gynecology, 2017, Volume: 29, Issue:6

    Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin

2017
[Aspirin: Indications and use during pregnancy].
    La Revue de medecine interne, 2017, Volume: 38, Issue:12

    Topics: Aspirin; Female; Fetal Death; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pregnancy,

2017
[Pregnancy and antiphospholipid antibodies].
    Presse medicale (Paris, France : 1983), 2008, Volume: 37, Issue:11

    Topics: Animals; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Complemen

2008
[The antiphospholipid syndrome in the 21st century].
    Medicina clinica, 2009, Sep-19, Volume: 133, Issue:10

    Topics: Adult; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Tri

2009
Lupus and pregnancy: integrating clues from the bench and bedside.
    European journal of clinical investigation, 2011, Volume: 41, Issue:6

    Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Azathioprine; Counseli

2011
Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis.
    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2013, Volume: 41, Issue:5

    Topics: Aspirin; Female; Fetal Death; Fetal Growth Retardation; Humans; Perinatal Mortality; Platelet Aggreg

2013
[Anticoagulation and antiaggregation during pregnancy].
    Therapeutische Umschau. Revue therapeutique, 2003, Volume: 60, Issue:1

    Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Abruptio Placentae; Administration, Oral; Adult;

2003
Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis.
    Birth defects research. Part B, Developmental and reproductive toxicology, 2003, Volume: 68, Issue:1

    Topics: Abnormalities, Drug-Induced; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Birth Weight;

2003
[Factor V Leiden mutation and pregnancy complications].
    Medicina (Kaunas, Lithuania), 2003, Volume: 39, Issue:9

    Topics: Abortion, Spontaneous; Activated Protein C Resistance; Adult; Anticoagulants; Aspirin; Factor V; Fem

2003
Antiphospholipid syndrome and second- or third-trimester fetal death: follow-up in the next pregnancy.
    European journal of obstetrics, gynecology, and reproductive biology, 2004, Jun-15, Volume: 114, Issue:2

    Topics: Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Arteries; Aspirin; Female; Fetal Deat

2004
Evidence-based treatment of the antiphospholipid syndrome: I. Pregnancy failure.
    Thrombosis research, 2004, Volume: 114, Issue:2

    Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; Ev

2004
Pregnancy in essential thrombocythaemia: experience with 40 pregnancies.
    European journal of haematology, 2004, Volume: 73, Issue:6

    Topics: Abortion, Spontaneous; Anticoagulants; Aspirin; Eclampsia; Female; Fetal Death; Finland; Humans; Pla

2004
[Thrombophilias and vascular placental pathology. A survey of the literature].
    La Revue de medecine interne, 2005, Volume: 26, Issue:2

    Topics: Activated Protein C Resistance; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Cohort Studies;

2005
[Acute poisoning: general management and main causes].
    La Revue du praticien, 2006, Sep-30, Volume: 56, Issue:14

    Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Alcoholic Intoxication; Amphetamines; Analgesics;

2006
[Newborn from mother with antiphospholipid syndrome].
    Polskie Archiwum Medycyny Wewnetrznej, 2006, Volume: 115, Issue:5

    Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; beta 2-Glycoprotein I; Female; Fet

2006
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Antiplatelet agents for preventing pre-eclampsia and its complications.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P

2007
Adverse pregnancy outcome, the uteroplacental interface, and preventive strategies.
    Seminars in perinatology, 2007, Volume: 31, Issue:4

    Topics: Anticoagulants; Aspirin; Female; Fetal Death; Fetal Growth Retardation; Heparin; Humans; Immunoglobu

2007
Analgesics during pregnancy.
    The American journal of medicine, 1983, Nov-14, Volume: 75, Issue:5A

    Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Birth Weight; Female; Fetal Death;

1983
The electrocardiogram of fetal and newborn rats and dysrhythmias induced by toxic exposure.
    Progress in clinical and biological research, 1983, Volume: 140

    Topics: Animals; Animals, Newborn; Arrhythmias, Cardiac; Aspirin; Dose-Response Relationship, Drug; Electroc

1983
[Pregnancy in essential thrombocythemia. Manifestation time and risk for mother and child].
    Deutsche medizinische Wochenschrift (1946), 1995, Nov-03, Volume: 120, Issue:44

    Topics: Abortion, Spontaneous; Adult; Aspirin; Female; Fetal Death; Growth Disorders; Humans; Infant, Newbor

1995
Therapy and prevention of thrombotic thrombocytopenic purpura during pregnancy: a clinical study of 16 pregnancies.
    American journal of hematology, 1996, Volume: 51, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Aspirin; Combined Modality Therapy; Diagnostic Errors; Dipyridamole;

1996
Prevention of fetal death in the antiphospholipid antibody syndrome.
    Lupus, 1996, Volume: 5, Issue:5

    Topics: Adrenal Cortex Hormones; Animals; Antiphospholipid Syndrome; Aspirin; Female; Fetal Death; Heparin;

1996
Essential thrombocythemia and pregnancy.
    Leukemia & lymphoma, 1996, Volume: 22 Suppl 1

    Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Aspirin; Busulfan; Combined Modality Therapy; Di

1996
[Intra-uterine fetal death syndrome--not only a gynecologic problem].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 1997, Volume: 2, Issue:8

    Topics: Adrenocorticotropic Hormone; Aspirin; Blood Coagulation Disorders; Female; Fetal Death; Heparin; Hum

1997
[Phospholipid antigens, thrombosis and repeated fetal death].
    Duodecim; laaketieteellinen aikakauskirja, 1996, Volume: 112, Issue:3

    Topics: Abortion, Habitual; Adult; Antigens; Aspirin; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female;

1996
[Aspirin and antiphospholipid syndrome].
    La Revue de medecine interne, 2000, Volume: 21 Suppl 1

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antiphospholipid Syndrome; Arteriosc

2000
[Diagnosis and management for antiphospholipid syndrome].
    Rinsho byori. The Japanese journal of clinical pathology, 2000, Volume: 48, Issue:5

    Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Female

2000
Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review.
    BMJ (Clinical research ed.), 2001, Feb-10, Volume: 322, Issue:7282

    Topics: Aspirin; Female; Fetal Death; Humans; Infant, Newborn; Obstetric Labor, Premature; Platelet Aggregat

2001
A single institutional experience with 43 pregnancies in essential thrombocythemia.
    European journal of haematology, 2001, Volume: 66, Issue:3

    Topics: Abortion, Induced; Abortion, Spontaneous; Abruptio Placentae; Adult; Anticoagulants; Aspirin; Busulf

2001
A literature review on the antiphospholipid syndrome and the effect on childbearing.
    Midwifery, 2001, Volume: 17, Issue:2

    Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Embolism; Female; Fetal Death; Fetal Diseases; F

2001
Do acetylsalicylic acid and other antiplatelet drugs prevent preeclampsia?
    Canadian family physician Medecin de famille canadien, 2001, Volume: 47

    Topics: Aspirin; Autoimmune Diseases; Clinical Trials as Topic; Diabetes Complications; Dose-Response Relati

2001
Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment. A comparative analysis of the literature.
    Acta haematologica, 2002, Volume: 107, Issue:3

    Topics: Abortion, Spontaneous; Aspirin; Blood Component Removal; Female; Fetal Death; Gestational Age; Human

2002
On the use of blockers of prostaglandin synthesis in the control of labor.
    Advances in prostaglandin and thromboxane research, 1978, Volume: 4

    Topics: Animals; Aspirin; Clinical Trials as Topic; Female; Fetal Death; Fetus; Hemodynamics; Humans; Indome

1978
Aspirin in pregnancy: maternal and fetal effects.
    Pediatrics, 1978, Volume: 62, Issue:5 Pt 2 Sup

    Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Birth Weight; Cleft Lip; Cleft Palate; Female; Fetal

1978
Antiphospholipid syndrome: laboratory concerns, fetal loss, and pregnancy management.
    Seminars in perinatology, 1991, Volume: 15, Issue:3

    Topics: Adrenal Cortex Hormones; Aspirin; Autoimmune Diseases; Female; Fetal Death; Heparin; Humans; Phospho

1991
Lupus anticoagulant and pregnancy.
    American journal of obstetrics and gynecology, 1985, Oct-01, Volume: 153, Issue:3

    Topics: Aspirin; Autoantibodies; Blood Coagulation Factors; Female; Fetal Death; Fetal Diseases; Fetal Growt

1985

Trials

10 trials available for aspirin and Fetal Death

ArticleYear
Effect of aspirin in prevention of adverse pregnancy outcome in women with elevated alpha-fetoprotein.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2014, Volume: 27, Issue:6

    Topics: Adult; alpha-Fetoproteins; Aspirin; Female; Fetal Death; Humans; Pre-Eclampsia; Pregnancy; Pregnancy

2014
Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder.
    Blood, 2004, May-15, Volume: 103, Issue:10

    Topics: Aspirin; Birth Weight; Enoxaparin; Female; Fetal Death; Folic Acid; Heparin, Low-Molecular-Weight; H

2004
Aspirin desensitization in the treatment of antiphospholipid syndrome during pregnancy in ASA-sensitive patients.
    American journal of reproductive immunology (New York, N.Y. : 1989), 2006, Volume: 55, Issue:1

    Topics: Adult; Antiphospholipid Syndrome; Aspirin; Desensitization, Immunologic; Female; Fetal Death; Follow

2006
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
    Lancet (London, England), 1994, Mar-12, Volume: 343, Issue:8898

    Topics: Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant Mortalit

1994
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
    Lancet (London, England), 1994, Mar-12, Volume: 343, Issue:8898

    Topics: Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant Mortalit

1994
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
    Lancet (London, England), 1994, Mar-12, Volume: 343, Issue:8898

    Topics: Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant Mortalit

1994
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
    Lancet (London, England), 1994, Mar-12, Volume: 343, Issue:8898

    Topics: Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant Mortalit

1994
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
    Lancet (London, England), 1994, Mar-12, Volume: 343, Issue:8898

    Topics: Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant Mortalit

1994
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
    Lancet (London, England), 1994, Mar-12, Volume: 343, Issue:8898

    Topics: Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant Mortalit

1994
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
    Lancet (London, England), 1994, Mar-12, Volume: 343, Issue:8898

    Topics: Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant Mortalit

1994
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
    Lancet (London, England), 1994, Mar-12, Volume: 343, Issue:8898

    Topics: Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant Mortalit

1994
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
    Lancet (London, England), 1994, Mar-12, Volume: 343, Issue:8898

    Topics: Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant Mortalit

1994
[Acetylsalicylic acid and kurantil in the prevention of pregnancy complications in glomerulonephritis and hypertension].
    Terapevticheskii arkhiv, 1993, Volume: 65, Issue:6

    Topics: Abortion, Spontaneous; Analysis of Variance; Aspirin; Chronic Disease; Dipyridamole; Drug Therapy, C

1993
ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pré-eclampsia com Aspirina) Collaborative Group.
    British journal of obstetrics and gynaecology, 1996, Volume: 103, Issue:1

    Topics: Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Follow-Up Studies; Humans; Obs

1996
Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications.
    British journal of obstetrics and gynaecology, 1998, Volume: 105, Issue:3

    Topics: Adult; Aspirin; Barbados; Birth Weight; Delayed-Action Preparations; Female; Fetal Death; Gestationa

1998
Antiphospholipid antibodies and pregnancy.
    Annals of the New York Academy of Sciences, 1999, Jun-22, Volume: 876

    Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Birth Rate; Female; Fetal

1999
On the use of blockers of prostaglandin synthesis in the control of labor.
    Advances in prostaglandin and thromboxane research, 1978, Volume: 4

    Topics: Animals; Aspirin; Clinical Trials as Topic; Female; Fetal Death; Fetus; Hemodynamics; Humans; Indome

1978
Prevention of perinatal consequences of pre-eclampsia with low-dose aspirin: results of the epreda trial. The Epreda Trial Study Group.
    European journal of obstetrics, gynecology, and reproductive biology, 1991, Aug-20, Volume: 41, Issue:1

    Topics: Abruptio Placentae; Aspirin; Birth Weight; Dipyridamole; Double-Blind Method; Drug Combinations; Fem

1991

Other Studies

74 other studies available for aspirin and Fetal Death

ArticleYear
The prevalence and perinatal repercussions of preeclampsia after the implementation of a prophylaxis protocol with aspirin.
    Pregnancy hypertension, 2023, Volume: 33

    Topics: Aspirin; Brazil; Female; Fetal Death; Fetal Growth Retardation; Gestational Age; Humans; Infant, New

2023
Pregnancy in patients with myelofibrosis: Mayo-Florence series of 24 pregnancies in 16 women.
    British journal of haematology, 2021, Volume: 195, Issue:1

    Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Diabetes, Gestational; Female; Fetal Death; Hemo

2021
Aspirin non-responsiveness in pregnant women at high-risk of pre-eclampsia.
    European journal of obstetrics, gynecology, and reproductive biology, 2018, Volume: 221

    Topics: Adult; Aspirin; Female; Fetal Death; Humans; Middle Aged; Platelet Aggregation Inhibitors; Pre-Eclam

2018
Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study.
    Autoimmunity, 2015, Volume: 48, Issue:1

    Topics: Abortion, Habitual; Adult; Aspirin; Autoantibodies; Autoimmune Diseases; Cell Movement; Chorionic Vi

2015
Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2015, Volume: 26, Issue:3

    Topics: Abortion, Habitual; Anticoagulants; Apgar Score; Aspirin; Birth Weight; Blood Coagulation Factors; D

2015
Clinical characteristics of pregnancies with a history of recurrent miscarriage at a Japanese perinatal center.
    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2015, Volume: 82, Issue:1

    Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Case-Control Studies; Cesarean Section; Female;

2015
Aspirin adherence during high-risk pregnancies, a questionnaire study.
    Pregnancy hypertension, 2016, Volume: 6, Issue:4

    Topics: Adult; Aspirin; Female; Fetal Death; Fetal Growth Retardation; Health Knowledge, Attitudes, Practice

2016
High-dose unfractionated heparin therapy in a pregnant patient with antiphospolipid syndrome: a case report.
    International journal of rheumatic diseases, 2010, Volume: 13, Issue:3

    Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Blood Coagulation; Cesarean Section; Drug Monito

2010
Outcomes and treatment of obstetrical antiphospholipid syndrome in women with low antiphospholipid antibody levels.
    Journal of reproductive immunology, 2012, Volume: 94, Issue:2

    Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Comorbi

2012
Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspects.
    Archives of gynecology and obstetrics, 2013, Volume: 288, Issue:1

    Topics: Algorithms; Anticoagulants; Aspirin; Body Mass Index; Female; Fetal Death; Fetal Growth Retardation;

2013
EFFECT OF ACETYLSALICYLIC ACID ON FOETAL RABBITS.
    Lancet (London, England), 1964, Apr-04, Volume: 1, Issue:7336

    Topics: Abnormalities, Drug-Induced; Aspirin; Female; Fetal Death; Fetus; Humans; Maternal-Fetal Exchange; P

1964
[Which abortion prevention should be chosen in the case of antiphospholipid syndrome?].
    Deutsche medizinische Wochenschrift (1946), 2004, Jun-04, Volume: 129, Issue:23

    Topics: Abortion, Spontaneous; Adrenal Cortex Hormones; Adult; Anticoagulants; Antiphospholipid Syndrome; As

2004
Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia.
    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2007, Volume: 29, Issue:10

    Topics: Abruptio Placentae; Adult; Anticoagulants; Aspirin; Dalteparin; Drug Therapy, Combination; Female; F

2007
Antiplatelet agents for prevention of pre-eclampsia.
    Lancet (London, England), 2007, Nov-17, Volume: 370, Issue:9600

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Fetal Death; Humans; Infant Mortality; Inf

2007
Fetal survival after prednisone suppression of maternal lupus-anticoagulant.
    Lancet (London, England), 1983, Jun-18, Volume: 1, Issue:8338

    Topics: Adult; Antibodies, Antinuclear; Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Fem

1983
Lupus anticoagulant in pregnancy.
    British journal of obstetrics and gynaecology, 1984, Volume: 91, Issue:4

    Topics: Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Chorea; Drug Therapy, Combination;

1984
Thrombotic thrombocytopenic purpura mimicking toxemia of pregnancy.
    American journal of obstetrics and gynecology, 1984, Oct-01, Volume: 150, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Aspirin; Diagnosis, Differential; Dipyridamole; Female; Fetal Death;

1984
Correction of pregnancy-related thrombocytopenia with aspirin without improvement in fetal outcome.
    American journal of obstetrics and gynecology, 1983, Aug-01, Volume: 146, Issue:7

    Topics: Aspirin; Dose-Response Relationship, Drug; Female; Fetal Death; Fetal Growth Retardation; Humans; Pl

1983
Effects of aspirin and related drugs in vitamin E-deficient rats.
    The Journal of nutrition, 1980, Volume: 110, Issue:10

    Topics: Animals; Aspirin; Blood Cell Count; Female; Fetal Death; Hematocrit; Hemoglobins; Hemolysis; Male; P

1980
Aplasia cutis congenita, elevated alpha-fetoprotein, and a distinct amniotic fluid acetylcholinesterase electrophoretic band.
    American journal of perinatology, 1994, Volume: 11, Issue:2

    Topics: Acetylcholinesterase; Adult; alpha-Fetoproteins; Amniotic Fluid; Aspirin; Diseases in Twins; Ectoder

1994
Prevention of preeclampsia with low-dose aspirin.
    The New England journal of medicine, 1994, Mar-17, Volume: 330, Issue:11

    Topics: Aspirin; Chi-Square Distribution; Female; Fetal Death; Humans; Pre-Eclampsia; Pregnancy

1994
Hepatic infarction during pregnancy complicated by antiphospholipid syndrome.
    American journal of obstetrics and gynecology, 1993, Volume: 169, Issue:1

    Topics: Adult; Antiphospholipid Syndrome; Aspirin; Female; Fetal Death; Humans; Infarction; Liver; Prednisol

1993
Combined corticosteroid and aspirin treatment for the high risk lupus pregnancy.
    British journal of obstetrics and gynaecology, 1993, Volume: 100, Issue:6

    Topics: Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Fetal Death; Gestational Age;

1993
Lupus anticoagulant. Significance in habitual first-trimester abortion.
    The Journal of reproductive medicine, 1993, Volume: 38, Issue:7

    Topics: Abortion, Habitual; Adult; Aspirin; Female; Fetal Death; Fetal Growth Retardation; Humans; Lupus Coa

1993
Low-dose aspirin therapy and placental pathology in women with poor prior pregnancy outcomes.
    American journal of reproductive immunology (New York, N.Y. : 1989), 1995, Volume: 34, Issue:3

    Topics: Adolescent; Adult; Aspirin; Drug Administration Schedule; Eclampsia; Female; Fetal Death; Humans; Pl

1995
Perinatal morbidity in chronic hypertension.
    British journal of obstetrics and gynaecology, 1996, Volume: 103, Issue:2

    Topics: Adult; Aspirin; Chronic Disease; Cohort Studies; Female; Fetal Death; Humans; Hypertension; Infant M

1996
Efficacy of low dose prednisone plus aspirin in preventing spontaneous abortions and/or fetal deaths due to antiphospholipid antibodies: results of a pilot study.
    Autoimmunity, 1996, Volume: 24, Issue:2

    Topics: Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Aspirin; Drug Administration Schedule; D

1996
Pregnancy outcome. Influence of antiphospholipid antibody titer, prior pregnancy losses and treatment.
    The Journal of reproductive medicine, 1997, Volume: 42, Issue:1

    Topics: Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Fema

1997
[Abortions caused by anticardiolipin antibodies: prevention by low-dose acetylsalicylic acid].
    Sangre, 1997, Volume: 42, Issue:3

    Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Autoimmu

1997
Aspirin poisoning during pregnancy: increased fetal sensitivity.
    American journal of perinatology, 1998, Volume: 15, Issue:1

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Gas Analysis; Blood Glucose; Diu

1998
[Recurrent fetal death and antiphospholipid antibody syndrome. A case report].
    Ginecologia y obstetricia de Mexico, 1997, Volume: 65

    Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiphospholipid Syndrome;

1997
Titration of antiplatelet treatment in pregnant women at risk of preeclampsia.
    Thrombosis and haemostasis, 1998, Volume: 79, Issue:4

    Topics: Abortion, Spontaneous; Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation;

1998
A novel approach to the management of pregnancies complicated by uteroplacental insufficiency and previous stillbirth.
    The Australian & New Zealand journal of obstetrics & gynaecology, 1998, Volume: 38, Issue:4

    Topics: Adult; Aspirin; Drug Therapy, Combination; Female; Fetal Death; Fetal Growth Retardation; Fetal Moni

1998
Late normalisation of uterine artery velocimetry in high risk pregnancy.
    European journal of obstetrics, gynecology, and reproductive biology, 2001, Volume: 95, Issue:1

    Topics: Arteries; Aspirin; Blood Flow Velocity; Dose-Response Relationship, Drug; Female; Fetal Death; Human

2001
High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin.
    Arthritis and rheumatism, 2001, Volume: 44, Issue:6

    Topics: Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Fetal Death; Heparin;

2001
Four pregnancies in two patients with essential thrombocythaemia--a case report.
    Annals of the Academy of Medicine, Singapore, 2002, Volume: 31, Issue:3

    Topics: Adult; Aspirin; Combined Modality Therapy; Cyclooxygenase Inhibitors; Female; Fetal Death; Humans; H

2002
Perinatal mortality and birth-weight in relation to aspirin taken during pregnancy.
    Lancet (London, England), 1976, Jun-26, Volume: 1, Issue:7974

    Topics: Aspirin; Birth Weight; Black People; Female; Fetal Death; Humans; Infant, Newborn; Infant, Newborn,

1976
Aspirin during pregnancy.
    Lancet (London, England), 1976, Oct-09, Volume: 2, Issue:7989

    Topics: Aspirin; Female; Fetal Death; Fetus; Humans; Pregnancy

1976
Comparative distribution and embryotoxicity of acetylsalicylic acid in pregnant rats and rhesus monkeys.
    Toxicology and applied pharmacology, 1977, Volume: 41, Issue:1

    Topics: Animals; Aspirin; Embryo, Mammalian; Female; Fetal Death; Fetal Resorption; Haplorhini; Macaca mulat

1977
Aspirin: teratogenic evaluation in the dog.
    Teratology, 1979, Volume: 20, Issue:2

    Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Dogs; Dose-Response Relationship, Drug; Female; Fetal

1979
Potentiation of methotrexate embryolethality by aspirin in rats.
    Teratology, 1978, Volume: 17, Issue:1

    Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Body Weight; Drug Synergism; Embryo, Mammalian; Femal

1978
Analogous effects of zinc deficiency and aspirin toxicity in the pregnant rat.
    The Journal of nutrition, 1977, Volume: 107, Issue:7

    Topics: Aldosterone; Animals; Aspirin; Blood Coagulation; Calcium; Female; Fetal Death; Potassium; Pregnancy

1977
The effect of cortisone on the teratogenic action of acetylsalicylic acid and diphenylhydantoin in the mouse.
    Experientia, 1976, Jun-15, Volume: 32, Issue:6

    Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Cleft Palate; Cortisone; Drug Administration Schedule

1976
Effects of prenatal administration of acetylsalicylic acid in rats.
    Toxicology, 1975, Volume: 3, Issue:2

    Topics: Animals; Animals, Newborn; Aspirin; Behavior, Animal; Body Weight; Female; Fetal Death; Pregnancy; P

1975
[Aspirin and pregnancy].
    Lyon medical, 1975, Apr-13, Volume: 233, Issue:7

    Topics: Animals; Aspirin; Female; Fetal Death; Fetus; Humans; Pregnancy; Pregnancy Trimester, First; Pregnan

1975
Inhibition of RNA synthesis by acetyl salicylate and actinomycin D during early development in the mouse.
    Pediatric research, 1975, Volume: 9, Issue:8

    Topics: Animals; Aspirin; Autoradiography; Breeding; Dactinomycin; Depression, Chemical; Female; Fetal Death

1975
Prevention of miscarriage in antiphospholipid syndrome.
    Autoimmunity, 1992, Volume: 14, Issue:2

    Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Female;

1992
[Recurrent loss of pregnancy in patients with anticardiolipin antibodies (ACAb)].
    Revista chilena de obstetricia y ginecologia, 1992, Volume: 57, Issue:5

    Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Aspirin; Drug Therapy, Combination; Female;

1992
[A trial of low-dose aspirin therapy in high-risk pregnancy].
    Nihon Sanka Fujinka Gakkai zasshi, 1992, Volume: 44, Issue:7

    Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Calcium; Female; Fetal Death; Fetal Growth Retardation; Human

1992
The 'primary' antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients.
    Autoimmunity, 1991, Volume: 9, Issue:1

    Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin

1991
Reversible effects of triamcinolone and lack of effects with aspirin or L-656,224 on external genitalia of male Sprague-Dawley rats exposed in utero.
    Teratology, 1991, Volume: 44, Issue:5

    Topics: Abnormalities, Drug-Induced; Animals; Arachidonic Acid; Aspirin; Benzofurans; Female; Fetal Death; G

1991
Aspirin dose-dependently reduces alcohol-induced birth defects and prostaglandin E levels in mice.
    Teratology, 1991, Volume: 44, Issue:5

    Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Dose-Response Relationship, Drug; Ethanol; Female; Fe

1991
Essential thrombocythemia and complications of pregnancy.
    American journal of hematology, 1991, Volume: 36, Issue:3

    Topics: Abortion, Incomplete; Aspirin; Female; Fetal Death; Humans; Pregnancy; Pregnancy Complications, Hema

1991
[Aspirin and pregnancy].
    Nederlands tijdschrift voor geneeskunde, 1990, Jun-09, Volume: 134, Issue:23

    Topics: Aspirin; Blood Coagulation Factors; Female; Fetal Death; Fetal Growth Retardation; Humans; Hypertens

1990
[Fetal survival after the corticosteroid and low-dose aspirin regimen in a case of anti-phospholipid antibody syndrome].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1990, Volume: 31, Issue:7

    Topics: Adult; Aspirin; Autoantibodies; Autoimmune Diseases; Drug Therapy, Combination; Female; Fetal Death;

1990
Resorption of CBA/J x DBA/2 mouse conceptuses in CBA/J uteri correlates with failure of the feto-placental unit to suppress natural killer cell activity.
    Journal of reproduction and fertility, 1990, Volume: 89, Issue:1

    Topics: Animals; Aspirin; Female; Fetal Death; Fetal Resorption; Fetus; Gestational Age; Killer Cells, Natur

1990
Successful pregnancies of two patients with relapsing thrombotic thrombocytopenic purpura.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1989, Volume: 29, Issue:4

    Topics: Adult; Aspirin; Blood Transfusion; Combined Modality Therapy; Dipyridamole; Drug Therapy, Combinatio

1989
Pregnancy loss with phospholipid antibodies: improved outcome with aspirin containing treatment.
    The Australian & New Zealand journal of obstetrics & gynaecology, 1989, Volume: 29, Issue:3 Pt 2

    Topics: Abortion, Spontaneous; Antibodies; Aspirin; Female; Fetal Death; Humans; Lupus Erythematosus, System

1989
Prophylactic low-dose aspirin and dipyridamole in pregnancy.
    Lancet (London, England), 1988, Apr-23, Volume: 1, Issue:8591

    Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Fetal Death; Fetal Growth Retardation; Hum

1988
Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody.
    American journal of obstetrics and gynecology, 1989, Volume: 160, Issue:2

    Topics: Aspirin; Autoantibodies; Female; Fetal Death; Humans; Lupus Erythematosus, Systemic; Phospholipids;

1989
Obstetric complications associated with the lupus anticoagulant.
    The New England journal of medicine, 1985, Nov-21, Volume: 313, Issue:21

    Topics: Abortion, Spontaneous; Aspirin; Blood Coagulation Factors; Blood Coagulation Tests; Female; Fetal De

1985
Fatal in utero salicylism.
    Journal of forensic sciences, 1985, Volume: 30, Issue:3

    Topics: Aspirin; Female; Fetal Death; Gestational Age; Humans; Maternal-Fetal Exchange; Pregnancy; Suicide,

1985
Teratology in the Macaca mulatta.
    Teratology, 1968, Volume: 1, Issue:2

    Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Clomiphene; Encephalocele; Female; Fetal Death; Haplo

1968
Salicylate-induced foetal damage late in pregnancy. An experimental study in mice.
    Acta paediatrica Scandinavica. Supplement, 1971, Volume: 211

    Topics: Abnormalities, Drug-Induced; Animals; Animals, Newborn; Aspirin; Carbon Isotopes; Coumarins; Female;

1971
Initiation of human parturition. I. Mechanism of action of arachidonic acid.
    Obstetrics and gynecology, 1974, Volume: 44, Issue:5

    Topics: Abortifacient Agents; Abortion, Induced; Amniotic Fluid; Animals; Arachidonic Acids; Aspirin; Dogs;

1974
[Effect of an acetylsalicylic acid-quinidine-lithium-combination on the fertility of mice].
    Arzneimittel-Forschung, 1974, Volume: 24, Issue:11

    Topics: Administration, Oral; Animals; Animals, Newborn; Aspirin; Drug Combinations; Embryo, Mammalian; Fema

1974
The effect of anti-inflammatory drugs on parturition parameters in the rat.
    Prostaglandins, 1973, Volume: 4, Issue:1

    Topics: Acetates; Animals; Aspirin; Cortisone; Depression, Chemical; Female; Fetal Death; Gestational Age; L

1973
Aspirin and indomethacin prolong parturition in rats: evidence that prostaglandins contribute to expulsion of fetus.
    Nature, 1972, Nov-03, Volume: 240, Issue:5375

    Topics: Administration, Oral; Animals; Aspirin; Biological Assay; Chickens; Chromatography, Thin Layer; Fema

1972
Delay of parturition in the rat by anti-inflammatory agents which inhibit the biosynthesis of prostaglandins.
    Nature, 1972, Nov-03, Volume: 240, Issue:5375

    Topics: Acetates; Administration, Oral; Animals; Anti-Inflammatory Agents; Aspirin; Cortisone; Depression, C

1972
Salicylate poisoning.
    The New England journal of medicine, 1973, May-03, Volume: 288, Issue:18

    Topics: Adult; Aspirin; Female; Fetal Death; Humans; Poisoning; Pregnancy; Pregnancy Complications; Salicyla

1973
Salicylate-induced foetal damage during late pregnancy in mice: a comparison between sodium salicylate, acetylsalicylic acid and salicylsalicylic acid.
    Acta pharmacologica et toxicologica, 1971, Volume: 29, Issue:23

    Topics: Animals; Aspirin; Female; Fetal Death; Gestational Age; Hemorrhage; Liver Glycogen; Mice; Pregnancy;

1971
Teratogenic drugs--R.C.G.P. survey.
    British medical journal, 1970, Oct-17, Volume: 4, Issue:5728

    Topics: Abnormalities, Drug-Induced; Aspirin; Barbiturates; Female; Fetal Death; Hormones; Humans; Iron; Pre

1970
Studies on metabolism and identification of the causative agent in aspirin teratogenesis in rats.
    Teratology, 1971, Volume: 4, Issue:1

    Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Benzoates; Biotransformation; Female; Fetal Death; Fe

1971
[Effect of several drugs on the fetus].
    Akusherstvo i ginekologiia, 1967, Volume: 43, Issue:12

    Topics: Abnormalities, Drug-Induced; Aminopyrine; Animals; Aspirin; Benzimidazoles; Chlorpromazine; Cortison

1967